Keeping Track: Ilaris Adds Three Rare Disease Claims; Sirukumab Submitted; Exondys 51's Surprising Approval
The latest drug development news and highlights from our FDA Performance Tracker.
The latest drug development news and highlights from our FDA Performance Tracker.